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I N F O  
 







venoms as tools 
  
Herbal medicines represent an advantageous alternative for the prevention and treatment of several 
diseases when compared to allopathic medicines. Averrhoa carambola (Oxalidaceae) is a plant rich in 
phenolic compounds and popularly known for its medicinal properties such as anti-inflammatory, 
antioxidant, and hypoglycemic. Different enzymes of the human organism participate in physiological 
processes which involve hemostasis, inflammation, and formation of new tissue. These enzymes are 
highlighted as pharmaceutical targets for the treatment of numerous pathologies. The present work 
evaluated the aqueous and ethanolic extracts from A. carambola leaves on phospholipase, hemolytic, 
caseinolytic, thrombolytic, coagulant, and fibrinogenolytic activities induced by phospholipases A2 
and proteases. Phenolic compounds and total flavonoids were quantified in the aqueous and ethanolic 
extracts of the leaves of Averrhoa carambola. These extracts were evaluated, in vitro, on 
phospholipase, proteolytic, hemolytic, thrombolytic and fibrinogenolytic activities induced by snake 
venoms. The results confirm the pharmacological potential of A. carambola since the extracts were 
able to modulate all evaluated activities related to hemostasis through inhibitions or potentiation of 
the enzymatic activities (phospholipases A2 and proteases). The constituents of A. carambola may act 
interfering in processes such as coagulation, thrombus dissolution, and fibrinogenolysis. 
 
  




produtos naturais plantas 
medicinais compostos 
fenólicos peçonhas como 
ferramentas 
 
Modulação da hemostasia por inibição enzimática exercida por folhas de Averrhoa carambola 
Os medicamentos fitoterápicos representam uma alternativa vantajosa para a prevenção e tratamento 
de diversas doenças quando comparados aos medicamentos alopáticos. Averrhoa carambola (Oxali-
daceae) é uma planta rica em compostos fenólicos e popularmente conhecida por suas propriedades 
medicinais como anti-inflamatória, antioxidante e hipoglicêmica. Diferentes enzimas do organismo 
humano participam de processos fisiológicos que envolvem hemostasia, inflamação e formação de 
novos tecidos. Essas enzimas são destacadas como alvos farmacêuticos para o tratamento de inúmeras 
patologias. O presente trabalho avaliou os extratos aquoso e etanólico das folhas de A. carambola 
sobre as atividades fosfolipásica, hemolítica, caseinolítica, trombolítica, coagulante e fibrinogenolíti-
ca induzidas por fosfolipases A2 e proteases. Compostos fenólicos e flavonoides totais foram quantifi-
cados nos extratos aquoso e etanólico das folhas de A. carambola. Esses extratos foram avaliados, in 
vitro, sobre as atividades fosfolipásica, proteolítica, hemolítica, trombolítica e fibrinogenolítica indu-
zidas por peçonhas de serpentes. Os resultados confirmam o potencial farmacológico de A. carambola 
uma vez que os extratos foram capazes de modular todas as atividades avaliadas relacionadas à he-
mostasia por meio de inibições ou potencialização das atividades enzimáticas (fosfolipases A2 e pro-
teases). Os constituintes de A. carambola podem atuar interferindo em processos como coagulação, 
dissolução de trombos e fibrinogenólise. 
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The most popular and ancient method in the 
treatment of diseases is using herbal medicine. 
Plants constitute a rich source of bioactive 
compounds, and many drugs that are available in 
the market were obtained directly or indirectly 
from them (Dehelean et al., 2021). Approximately 
50% of all medicines have their origin from 
plants, which demonstrate their essential role in 
the development of the pharmaceutical industry 
(Glasl and Khan, 2018). Data from the World 
Health Organization (WHO) show that more than 
80% of the world population depends on herbal 
medicines for disease prevention and treatment. 
Many herbal medicines have advantages 
compared to the allopathic ones, such as low cost 
to obtain, greater safety in their use, and fewer 
adverse effects (Ahmad and Sharma, 2020).  
One of the aggravating factors of ophidian 
accidents is the local effect, which is conditioned 
to tissue damages such as necrosis, edema, 
myotoxicity, and hemorrhage. Envenoming is 
caused by the collective action of different classes 
of toxins, such as phospholipases A2, 
metalloproteases, serine proteases, L-amino acid 
oxidases, and hyaluronidases (Gutiérrez et al., 
2007).  
Some plants are rich in bioactive compounds 
that are responsible for inhibiting the toxic and 
pharmacological effects induced by snake venoms, 
acting as enzymatic inhibitors (Urs et al., 2013). 
Due to the large number of biological activities 
induced by these toxins and the high degree of 
homology that many of them present with 
enzymes of the human organism, numerous 
researches have been developed using snake 
toxins and venoms as tools to induce 
pharmacological effects and simulate the 
modulation of human enzymes (Romero et al., 
2010).  
Several investigations involve mechanisms of 
action of natural compounds that act as enzymatic 
inhibitors, and the main classes of toxins used as 
targets are those involved in inflammatory 
response and hemostasis (phospholipases A2, 
metalloproteases, and serine proteases) (Bijak et 
al., 2014; Braga et al., 2019; Marques et al., 2019). 
However, mechanisms of interaction between 
enzymes and natural compounds are poorly 
described and require extensive studies of 
structural and functional characterization (Moura-
da-Silva et al., 2016), thus enabling future 
applications of these compounds in the therapy of 
human diseases.  
Studies point out to different parts of Averrhoa 
carambola L. to have pharmacological properties 
such as antioxidant, anti-inflammatory, 
hepatoprotective, and anti-ulcer activity in leaves 
and stems (Cabrini et al., 2011). Phytochemical 
analyses of the leaves revealed the presence of 
bioactive compounds such as saponins, alkaloids, 
flavonoids, and tannins (Thomas et al., 2008).  
The objective of this study was to perform the 
toxicological and pharmacological 
characterization of the aqueous and ethanolic 
extracts of A. carambola leaves, evaluating their 
action on hemostasis and enzymatic activities 
(exerted by phospholipases A2 and proteases). 
Venoms of different snakes were used as tools 
once they are rich sources of these enzymes and 
are already broadly characterized. 
MATERIAL AND METHODS 
Collection and identification of plant material 
Leaves of Averrhoa carambola (Oxalidaceae) 
were collected in an orchard in the city of Lavras, 
MG, Brazil (altitude 845 m, latitude 21.15 ° S, and 
longitude 45.22 ° W), in December of 2015. The 
leaves were dried on a forced air oven at 35 °C 
and then milled in a Willey type mill. The powder 
obtained was kept at room temperature. The 
exsiccates of the species were deposited at the 
Herbarium of the Federal University of Lavras, 
Brazil, under registration no. 24201.  
Preparation of aqueous and ethanolic extracts  
The powder obtained from the leaves of A. 
carambola was used to prepare extracts in two 
different solvents: water (infusion for 30 minutes 
of 40 g in 400 mL of freshly boiled water) and 
ethanol (percolation at 92.8 °C and room 
temperature). The residual solvent in the ethanolic 
extract was removed in a rotary evaporator at 40 
°C. After this process, the aqueous and ethanolic 
extracts were frozen and then lyophilized. Both 
extracts were weighed and dissolved in PBS for 
analysis.  
Total phenolic compounds 
The determination of the total phenolic 
compounds of the aqueous and ethanolic extracts 
from A. carambola leaves was performed 
according to the method of Folin-Denis (Anvisa, 
2010). The results were expressed as mg 
compounds/100 g of sample. The analytical curve 
was performed with five concentrations of tannic 
acid (4, 8, 12, 16, and 20 μg mL-1). 
Total flavonoids 
The methodology described by Woisky and 
Salatino (1998) was used for the determination of 
flavonoid contents. Lyophilized (0.1 g) samples of 
the aqueous and ethanolic extracts from A. 
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carambola leaves were weighed and dissolved in 
25 mL of methanol. Aliquots of 50, 200, and 400 
μL of each extract were added to 500 μL of a 
methanolic solution of aluminum chloride 2% 
(w:v-1) and the volume filled with methanolic 
acetic acid solution 5% (v:v-1). After 30 minutes, 
absorbances were read at 425 nm. The analytical 
curve was performed with aliquots of 50, 100, 
200, 300, 400, and 500 μL of quercetin (QE) at 
100 μg mL-1. 
Snake venoms 
Venoms of Bothrops, Crotalus durissus 
terrificus (C.d.t.), and Lachesis muta were used as 
the source of enzymes to induce the different 
activities. They were purchased from the 
serpentarium Bioagents (Batatais city, state of São 
Paulo, Brazil) and previously evaluated in 
different doses to define the minimum effective 
dose adequate for each activity. The venoms were 
weighed and dissolved in PBS, pH 7.4, to perform 
the assays. 
Obtaining human blood 
The blood was obtained from healthy 
volunteers, and collected in tubes containing 
heparin (hemolytic activity), citrate (coagulant 
activity), and without anticoagulant (thrombolytic 
activity).  
All tests using human blood or its components 
were carried out with the previous authorization of 
the Ethics Committee on Human Research 
(COEP) of the Federal University of Lavras, under 
the registration number: CAAE: 
56619816.6.0000.5148. 
Phospholipase and hemolytic activity 
The phospholipase and hemolytic activities 
were evaluated in a solid medium, as described by 
Gutiérrez et al. (1988). The gel for the evaluation 
of the phospholipase activity was prepared with 
0.01 mol L-1 CaCl2, egg yolk lecithins 1:3 v:v, 
PBS (pH 7.4), 1% bacteriological agar, and 
0.005% sodium azide. The medium was poured 
into Petri dishes at 45-50 °C. After gel 
solidification, the treatments were applied in 0.5 
cm diameter holes, and the dishes were maintained 
in a cell culture chamber for 12 hours at 37 °C.  
The gel was made, for the hemolytic activity, 
replacing the egg yolk lecithins with a human 
erythrocyte concentrate calculated to get a 
hematocrit of 1%. The newly collected blood was 
centrifuged at 900 g for 5 minutes to obtain the 
erythrocytes. The erythrocytes was then suspended 
in 5 mmol L-1 of PBS (pH 7.4) and centrifuged 
under the same conditions, repeating this washing 
step twice.  
The inhibition of phospholipase (Bothrops 
jararacussu, B. moojeni, and B. alternatus) and 
hemolytic (B. moojeni, B. atrox, and Crotalus 
durissus terrificus (C.d.t.)) activities induced by 
snake venoms was evaluated by their previous 
incubation with extracts from A. carambola leaves 
for 30 minutes at 37 ºC in different proportions 
(venom: extract, w:w). Controls containing only 
venoms or extracts were also performed. 
Caseinolytic activity 
A gel was prepared following the methodology 
of the phospholipase activity described by 
Gutiérrez et al. (1988), replacing egg yolk 
lecithins with a casein solution. The casein 
concentration was adjusted to 1% per test. The 
venoms of B. jararacussu, and B. moojeni (30 μg) 
and A. carambola leaf extracts were preincubated 
in the proportions of 1:0.5, 1:1, 1:2, 1:4, and 1:8 
(venom: extract, w:w) for 30 minutes at 37 °C. 
Samples were then applied to orifices made in the 
gel, followed by incubation for a period of 12 
hours at 37 °C in a cell culture chamber.  
The activities described in phospholipase, 
hemolytic, and caseinolyticwere evaluated by 
measuring the diameters of the translucent halos 
formed in the gel around the holes. The results 
were expressed in percentage, in which the 
controls containing snake venom corresponded to 
100% of activity. 
Thrombolytic activity 
The thrombolytic activity was assessed on 
human blood clots formed in vitro, according to 
the methodology described by Cintra et al. (2012). 
The clots were incubated for 24 hours at 37 ºC 
with the samples containing B. atrox, B. moojeni, 
and Lachesis muta (40 μg) venoms, PBS, or the 
venoms previously incubated (30 minutes at 37 
ºC) with A. carambola leaf extracts in the 
proportions of 1:0.5, 1:1, 1:2, and 1:4 (venom: 
extract, w:w). The activities were calculated by 
measuring the volume of fluid released by each 
thrombus. The data were converted in percentage, 
and the controls containing only venoms were 
considered as 100% activity. 
Coagulant / anticoagulant activity 
The evaluation of clotting time was performed 
according to Rodrigues et al. (2000). The leaf 
extracts from A. carambola were previously 
incubated with the C.d.t., L. muta, and B. atrox 
venoms for 10 minutes at 37 °C in the proportions 
of 1:0.1, 1:0.25, 1:0.5, 1:1, 1:2, and 1:4 (venom: 
extract, w:w). Tubes containing citrated plasma 
were kept in a 37 °C bath. The incubated samples 
were added to the plasma (200 μL), and then the 
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time until the formation of a rigid clot was 
measured. The minimum coagulant dose was 
previously defined, which was the lowest amount 
of venom capable of inducing plasma coagulation 
in a range between 50 and 180 seconds. 
Fibrinogenolylis activity 
The protease inhibition assays were performed 
through the preincubation of B. moojeni venom 
(60 μg) with leaf extracts of A. carambola in the 
proportions of 1:2.5, 1:5, and 1:10 (venom: 
extract, w:w), for 30 minutes at 37 °C. Then, the 
fibrinogen (60 μg) was added to the samples, and 
they remained at the same temperature for another 
90 minutes. The samples were analyzed in 12% 
polyacrylamide gel (w:v), allowing observation of 
the α, β, and γ fibrinogen chains (Laemmli, 1970). 
Controls containing venom and fibrinogen were 
also carried out. 
Statistical analysis 
The results were presented as the mean of 
triplicates ± standard deviation. The data were 
evaluated by analysis of variance, and the means 
were compared using the Scott Knott test (p 
<0.05) (R Core Team, 2012).  
RESULTS AND DISCUSSION 
Total phenolic compounds and total flavonoids 
The leaves of Averrhoa carambola are rich in 
flavonoids (Cazarolli et al., 2012; Islam et al., 
2020), and their medicinal properties are largely 
attributed to these compounds. A. carambola is 
scientifically proven to contain properties such as 
antioxidant, anti-inflammatory, and 
antihyperglycaemic (Moresco et al., 2012; Siddika 
et al., 2020; Yang et al., 2020) The ethanolic 
extract from leaves of A. carambola presented the 
highest total phenolic content (72.49 mg tannic 
acid/g) and total flavonoids (67.95 mg 
quercetin/g) (Table 1). In the literature, it was 
found that the ethanolic extract of A. carambola 
leaves produced 79.07 mg GAE/g for phenolic 
compounds and 35.25 mg QE/g for flavonoids 
(Moresco et al., 2012). However, in the present 
work, the flavonoid content was higher than in the 
literature. The different percentage of flavonoid 
concentration observed is possibly due to climatic 
disturbances and other regional variables to which 
the plants are subjected.
 
Table 1 - Contents of yields, total phenolic compounds, and total flavonoids in extracts of leaves of Averrhoa 
carambola 
 
Flavonoids are the most relevant products 
derived from plant material. Many of the 
biological activities reported for flavonoids 
(antitumor, antioxidant, and anti-inflammatory) 
(Ansari and Akhtar, 2019; Jucá et al., 2020), make 
these compounds to be pharmacologically active. 
They may interfere in the cell growth regulating 
pathways, energy metabolism, apoptosis, cell 
division, transcription, repair genes, inflammation, 
stress response, and may act on tumor formation 
(Havsteen, 2002). Thus, flavonoids are promising 
molecules in the treatment of tumors (Kapoor et 
al., 2021). 
Flavonoids act on cells that are involved in 
inflammation by inhibiting the proliferation of T 
lymphocytes, inhibit the production of 
proinflammatory cytokines (TNF-α and IL-1). 
They also act by modulating the activity of 
enzymes on the arachidonic acid pathways such as 
phospholipases A2, cyclooxygenase, and 
lipoxygenase (López-Posadas et al., 2008), which 
are essential mediators of the inflammatory 
response (Kim et al., 2004). Quercetin was the 
first flavonoid to inhibit the phospholipase A2 
activity of human neutrophils. Other flavonoids, 
such as hesperetin, naringenin, kaempferol, and 
myricetin, also inhibited the activity of 
phospholipase A2 (Lättig et al., 2007). The 
flavonoid luteolin inhibited the activity of the 
enzyme cyclooxygenase (COX) (Baumann et al., 
1980). Flavonols such as baicalin and catechin are 
inhibitors of the enzyme lipoxygenase (Burnett et 
al., 2007). 
Phospholipase activity 
The aqueous extract inhibited 30% of the 
phospholipase activity induced by B. moojeni 
venom in 1:0.5 and 1:2 (w:w) ratios and 40% and 
25% in the proportions of 1:1 and 1:8 (w:w), 
respectively. The ethanolic extract inhibited the 
activity induced by the same venom by 25% when 
evaluated in the ratios of 1:1 and 1:2 (w:w) and 
30% in 1:4 (w:w) ratio (Figure 1). 
When using the B. alternatus venom, the 
aqueous extract was responsible for 25% of 
inhibition after incubation at 1:1 and 1:2 (w:w) 
Extracts Yield % mg phenolic/ 100g sample  mg flavonoids /100g sample 
Aqueous 18.48 4950 1628 
EtOH 7.10 7249 6795 
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ratios, and 32% at 1:4 and 1:8 (w:w). Meanwhile, 
the ethanolic extract reduced 25% of 
phospholipase activity at 1:0.5 and 1:1 (w:w) 
ratios, and 32% in 1:2, 1:4, and 1:8 (w:w) ratios 
(Figure 1). 
 
Figure 1 - Phospholipase activity (%) induced by Bothrops moojeni, B. alternatus, and B. jararacussu 
venoms, previously incubated with the extracts of Averrhoa carambola. Control (+) containing only venom 
(10 μg) was considered as 100% activity. The results correspond to the means of triplicates obtained in each 
proportion (venom: extract, w:w) and their calculated standard deviations 
*Statistically different from the positive control. 
 
The inhibition of phospholipases A2 by natural 
compounds is substantial in the scientific context, 
mainly when aiming at the prospecting 
mechanisms of action of plant molecules present 
in therapeutically-used formulations for the 
treatment of numerous diseases. In addition, this 
inhibition is related to physiological processes 
involving inflammatory responses and blood 
coagulation (Dey and Nath, 2012; Hage-Melim et 
al., 2013). 
One of the inhibition mechanisms suggested in 
the literature demonstrate the action of plant 
compounds in the formation of complexes with 
calcium ions, interfering in their binding to the 
phospholipases A2 and, consequently, in the 
performance of their function as cofactors (Dey 
and Nath, 2012). 
Polyhydroxylated flavonoids are inhibitors of 
PLA2s (Kim et al., 2004). They can bind to amide 
groups of different proteins by strong hydrogen 
bonds (Mors et al., 2000). This interaction might 
be one of the possible mechanisms of inhibition 
that explains the reductions of the phospholipase 
activity observed in the present work.  
Hemolytic activity  
The extracts of A. carambola did not induce 
hemolysis under the conditions, concentrations, 
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and incubation time evaluated. 
The ethanolic extract showed inhibitory activity 
on the B. atrox venom, reducing 22% of its 
hemolytic activity at the 1:0.25 (w:w) ratio. On the 
other hand, the aqueous extract reduced 30% of 
the activity induced by the same venom at the 
1:0.1 and 1:0.25 ratios and 38% in the ratio of 
1:0.5 (w:w) (Figure 2A). 37% of the hemolytic 
activity induced by the venom of C.d.t. was 
reduced after incubation with the aqueous extract 
at the ratio of 1:0.5 (w:w), and 50% at 1:0.1 and 
1:0.25 (w:w) ratios  (Figure 2B). The B. moojeni 
venom had its activity inhibited in 22% when 
previously incubated with the aqueous extract in 
the ratio of 1:0.1 (w:w), and 27% when incubated 
with the ethanolic extract at the 1:0.25 and 1:0.5 
(w:w) ratios (Figure 2C). 
Figure 2 - Hemolytic activity (%) induced by Bothrops atrox (A), Crotalus durissus terrificus (C.d.t.) (B), 
and B. moojeni (C) venoms, previously incubated with the extracts of Averrhoa carambola. Controls (+) 
containing only venom were considered as 100% activity (B. atrox, 30 μg, C.d.t., 30 μg, and B. moojeni, 60 
μg). The results correspond to the means of triplicates obtained in each proportion (venom: extract, w:w) and 
their calculated standard deviations 
*Statistically different from the positive control. 
 
Félix-Silva et al. (2014), when evaluating the 
aqueous extract of leaves of Jatropha gossypiifolia 
L., observed the absence of hemolytic activity. In 
this type of extraction, a considerable amount of 
molecules are primary metabolites (e.g., proteins, 
amino acids, and carbohydrates), and would 
justify the absence of toxicity even when the 
extracts are evaluated in high concentrations.  
The hemostatic system components are the 
main physiological targets of venom toxins 
(Queiroz et al., 2017). It is suggested that the 
inhibitory effects presented by these extracts are 
due to the action of metabolites as enzymatic 
inhibitors, chemical inactivators, or 
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immunomodulators that interacted with target 
macromolecules (Mors et al., 2000).  
Caseinolytic activity 
The most significant inhibitions of the 
caseinolytic activity were observed for the B. 
moojeni venom, with an inhibition of 20% in the 
ratio of 1:8 (w:w) by the aqueous extract and 20 to 
27% in the ratios of 1:0.5; 1:4, and 1:8 (w:w) by 
the ethanolic extract (Figure 3A). Only the 
ethanolic extract, in the ratios 1:1 and 1:2 (w:w), 
exerted inhibition on the proteolytic activity 
induced by the B. alternatus venom (Figure 3B). 
The aqueous extracts potentiated the proteolytic 
activity induced by B. jararacussu venom in the 
1:1, 1:2, 1:4, and 1:8 (w:w) ratios and inhibited the 
proteolysis in 1:0.5 (w:w). The ethanolic extract, 
when previously incubated with the same venom, 
potentiated the activity by inducing 10% more 
proteolysis at the ratios of 1:4 and 1:8 (w:w) 
(Figure 3C). 
 
Figure 3 - Caseinolytic activity (%) induced by Bothrops moojeni (A), B. alternatus (B), and B. jararacussu 
(B) venoms, previously incubated with the extracts of Averrhoa carambola. Controls (+) containing only 
venom (10 μg) were considered as 100% activity. The results correspond to the means of triplicates obtained 
in each proportion (venom: extract, w: w) and their calculated standard deviations 
*Statistically different from the positive control. 
 
The aqueous extracts from Lannea acida and 
Bauhinia thonningii and the ethanolic extracts 
from Grewia mollis, Waltheria indica, and 
Pentanisia prunelloides inhibited 90% of the 
proteolysis activity induced by Bitis arietans 
venom. In these extracts were found significant 
amounts of polyphenols, such as tannins 
(Molander et al., 2014). They have vast medical 
applications and can interact with enzymes present 
in venoms, inactivating or reducing their activities 
(Pithayanukul et al., 2010).  
The ethanolic extract from the leaves of 
Renealmia alpinia inhibited a metalloprotease 
isolated from the venom of B. atrox by 25.9%, 
35.2%, 48.4%, 65.1%, and 75.8% in the 
proportions of 1:1, 1:2.5, 1:5, 1:10, and 1:20 
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(w:w), respectively. Flavonoids, terpenoids, and 
coumarins were found in this extract (Patiño et al., 
2013). The flavonoids gallocatechin and 
myricetin-3-o-glycoside were inhibitors of the 
metalloprotease activity (Vale et al., 2011).   
The direct action on enzymes present in 
venoms, through weak interactions, as well as 
interactions of plant compounds with cofactors 
essential for the catalytic activity of these 
enzymes, have already been described as 
mechanisms of action (Núñez et al., 2005). Plant 
extracts containing significant amounts of 
flavonoids can act as metal chelators and 
sequestration of zinc ions, which are essential for 
the catalytic activity of several proteases present 
in venoms (Mira et al., 2002). 
Thrombolytic activity 
The aqueous extract from leaves of A. 
carambola resulted in a significant increase in the 
thrombolytic activity induced by  B. atrox venom 
[75%, 85%, and 50% in the proportions of 1:0.5, 
1:1, and 1:2 (w:w), respectively]. The ethanolic 
extract also increased the thrombolytic activity by 
80%, 120%, 140%, and 40% in the ratios of 1:0.5, 
1:1, 1:2, and 1:4 (w:w), respectively (Figure 4A). 
Differently, the thrombolytic activity induced 
by L. muta venom was reduced in 30%, 43%, and 
45% after incubation with the aqueous extract in 
the ratios of 1:0.5, 1:2, and 1:4 (w:w), 
respectively. Significant inhibitions were also 
observed to the ethanolic extract, with reduced 
activity of 20% and 50% for the proportions 1:0.5 
and 1:4 (w:w), respectively (Figure 4B).  
The aqueous extract significantly increased the 
thrombolysis induced by B. moojeni venom in 
50% and 70% in the proportions of 1:1 and 1:2 
(w:w), respectively. However, when evaluated at 
the ratio of 1:0.5 (w:w), the aqueous extract 
inhibited 50% of the thrombolytic activity. The 
ethanolic extract, in the proportions of 1:1, 1:2 and 
1:4 (w:w), induced a significant increase (between 
30 and 48%) under the same conditions (Figure 
4C). 
Figure 4 - Thrombolytic activity (%) induced by the venoms from Bothrops atrox (A), Lachesis muta (B), 
and B. moojeni (C), previously incubated with the extracts of Averrhoa carambola. Controls (+) containing 
only venom (40 μg) were considered as 100% activity.The results correspond to the means of data triplicates 
obtained in each proportion (venom: extract, w:w) and their calculated standard deviations 
*Results are statistically different from the positive control. 
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The inhibition by natural compounds of some 
proteases present in snake venoms simulates the 
anticoagulant effects of these compounds on 
animal organisms since these proteases act on the 
factors of the coagulation cascade and exert 
similar thrombin function, exhibiting high 
homology with human enzymes (Marsh, 1994).  
The metalloproteinases in the Bothrops snakes 
venoms induce mainly hemorrhage and 
debridement of tissues, and these enzymes require 
bivalent ions as cofactors (e.g., zinc, calcium, 
magnesium) (Fox and Serrano, 2008). Tannins and 
flavonoids present in plant extracts inhibit 
metalloproteases by zinc chelation (Castro et al., 
1999), consequently preventing the degradation of 
the components responsible for the hemostatic 
balance. 
Some authors suggest the use of plant extracts 
in local administration to allow their inhibitory 
action in metalloproteases (Assafim et al., 2011).  
In the present study, the aqueous and ethanolic 
extracts of A. carambola showed anticoagulant 
activity (Table 2). In addition to the proposed 
mechanisms related to enzymatic inhibition, the 
inhibiyion may also be the result of the activity 
exerted by the flavonoids present in A. carambola 
leaves on the production of nitric oxide in blood 
platelets, inhibiting platelet aggregation and 
delaying the formation of blood clots (Bhowmick 
et al., 2014).  
Different proportions of the A. carambola 
extracts incubated with B. atrox and B. moojeni 
venoms presented thrombolytic activity (Figure 
4A and 4C), suggesting that flavonoids contained 
in the extracts may be acting as inhibitors of 
thrombin. Therefore, they have great potential for 
application in the treatment of thrombotic diseases 
(Bijak et al., 2014). 
On the other hand, when observing the results 
obtained for the activity of the extracts on the 
C.d.t. venom in the coagulation test (Table 2) and 
on the L. muta venom in the thrombolytic test 
(Figure 4B), it is suggested their potential 
application in the treatment of hemorrhagic 
diseases, since they accelerated the formation of a 
clot (procoagulant action) and significantly 
decreased the thrombolytic activity. 
Coagulant/anticoagulant activity 
The aqueous extract from A. carambola leaves 
exerted procoagulant activity, reducing the 
clotting time by 8 to 50 seconds, when previously 
incubated with the C.d.t. at the ratios 1:0.1, 1:0.25, 
1:1, 1:2, and 1:4 (w:w). The ethanolic extract 
showed procoagulant activity in the proportions of 
1:0.1, 1:0.25, and 1:1 (w:w), with reductions 
between 6 and 24 seconds. It also demonstrated 
anticoagulant activity at the ratios 1:2 and 1:4 
(w:w), which increased the clotting time by 15 and 
38 seconds, respectively (Table 2). 
 
Table 2 - Effect of the extracts from Averrhoa carambola leaves on the coagulant activity induced by 
different snake venoms 




Lachesis muta Bothrops atrox 




   
Aqueous extract 
1:0.1 136.00 ± 6.80 a 85.00 ± 4.25 b 90.00 ± 4.50 b 
1:0.25 167.00 ± 8.35 a 51.00 ± 2.55 a 49.00 ± 2.45  
1:1 125.00 ± 6.25 a 77.00 ± 3.85  50.00 ± 2.50  
1:2 153.00 ± 7.65 a 96.00 ± 4.80 b 88.00 ± 4.40 b 
1:4 158.00 ± 7.90 a 90.00 ± 4.50 b 69.00 ± 3.45 b 
 
Ethanolic extract 
1:0.1 151.00 ± 7.55 a 85.00 ± 4.25 b 57.00 ± 2.85 b 
1:0.25 155.00 ± 7.75 a 94.00 ± 4.70 b 39.00 ± 1.95 a 
1:1 169.00 ± 8.45 a 81.00 ± 4.05 b 65.00 ± 3.25 b 
1:2 190.00 ± 9.50 b 72.00 ± 3.60  83.00 ± 4.15 b 
1:4 213.00 ± 10.65 b 74.00 ± 3.70  81.00 ± 4.05 b 
a – Differ from the positive control (p < 0.05) - reduces time. 
b – Differ from the positive control (p < 0.05) - increases time. 
*The controls were carried out with 10 µg of each evaluated venom. 
The results are presented as the average of triplicates ± standard deviation p < 0.05. 
 
Incubations of L. muta venom with the aqueous 
extract increased the clotting time by 9 up to 20 
seconds, characterizing an anticoagulant action at 
the ratios of 1:0.1, 1:2, and 1:4 (w:w). It was 
observed procoagulant action only in the ratio of 
1:0.25 (w:w), with a reduction of 25 seconds in 
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clotting time (Table 2). The ethanolic extract was 
responsible for increasing the clotting time 
induced by the venom of L. muta when evaluated 
at the proportions of 1:0.1, 1:0.25, and 1:1 (w:w), 
with values between 5 and 18 seconds higher than 
the positive control (Table 2). 
Previous incubations of the aqueous extract 
with the B. atrox venom in the ratios 1:0.1, 1:2, 
and 1:4 (w:w) resulted in anticoagulant activity, 
with the clotting time increasing by 18 to 39 
seconds (Table 2). Similarly, the ethanolic extract 
increased the clotting time up to 32 seconds in the 
proportions of 1:0.1, 1:1, 1:2, and 1:4 (w:w). 
However, it induced procoagulant activity when 
evaluated at the ratio of 1:0.25 (w:w) (Table 2). 
Procoagulant and anticoagulant activities 
observed for the same extract (in different 
proportions) acting on the same venom suggests 
the presence of active substances that inhibits 
some classes of proteases or molecules that 
potentiate some classes of enzymes. Some 
hemorrhagic metalloproteinases act as 
anticoagulants, and the fibrinogenolytics ones act 
as procoagulants, generating fibrin networks. 
Serine proteases are responsible for forming 
friable clots that can also act as anticoagulants but 
with less efficiency. In addition, phospholipases 
A2 can act as pro-coagulants (Lu et al., 2005). 
Whether the extracts will be used to form a clot 
to stagnate hemorrhages or in the dissolution of 
clots, acting as anticoagulant agents of wide 
application in the treatment of cardiovascular 
diseases, knowing the different enzymes that act in 
blood coagulation is necessary to evaluate 
different concentrations of the extracts. Once that 
is properly done, defining the appropriate amounts 
of active substances that will provide a given 
plant's expected action is much easier. 
Fibrinogenolysis activity 
The two extracts evaluated were efficient in 
inhibiting fibrinogen molecules' degradation, 
induced by the B. moojeni venom, in all ratios 
evaluated (Figure 5). 
 
Figure 5 - Electrophoretic profile (SDS-PAGE) of the proteolytic action of Bothrops moojeni venom on 
fibrinogen. Effect of extracts from Averrhoa carambola leaves on the activity of the venom. 1- Fibrinogen 
(60 μg); 2- B. moojeni (60 µg) + fibrinogen; 3- B. moojeni; 4- B. moojeni + fibrinogen + aqueous extract of 
A. carambola (1:2.5 w:w); 5- B. moojeni + fibrinogen + aqueous extract of A. carambola (1:5 w:w); 6- B. 
moojeni + fibrinogen + aqueous extract of A. carambola (1:10 w:w); 7- B. moojeni + fibrinogen + ethanolic 
extract of A. carambola (1:2.5 w:w); 8- B. moojeni + fibrinogen + ethanolic extract of A. carambola (1:5 
w:w); 9- B. moojeni + fibrinogen + ethanolic extract of A. carambola (1:10 w:w). (a) Proteases present in the 
venom. (b) Phospholipases A2 present in the venom. (c) Fibrinopeptides released from the breakdown of the 
α and β chains of the fibrinogen molecules. 
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In our study, the extracts prevented the 
breakdown of fibrinogen (Figure 5) by proteolytic 
enzymes present in the venom, which results in 
the non-formation of the fibrin networks and 
consequently reducing the formation of clots. The 
coagulant activity results corroborate the 
inhibition presented in the fibrinogenolysis 
activity since clotting time prolongations were 
observed for the extracts in different ratios (Table 
2).  
One of the proposed mechanisms of action for 
plant molecules involves the formation of 
complexes with zinc ions in the binding sites 
present in the structures of metalloproteases, 
resulting in the inhibition of these enzymes 
(Moura-da-Silva et al., 2016). Thus, the 
inhibitions observed in the caseinolytic, 
thrombolytic, fibrinogenolytic, and coagulant 
activities of the present study, whose proteases 
play a fundamental role, can be partially attributed 
to the formation of ionic complexes with plant 
compounds. 
The ability of flavonoids to bind to amide 
groups of proteins by hydrogen bonds 
(Pithayanukul et al., 2010) can result in structural 
alterations that lead to a partial or total loss of 
activities performed by enzymes. This is one more 
type of mechanism of action that would explain 
the inhibitions of proteases observed in the present 
work. 
CONCLUSIONS 
The extracts of Averrhoa carambola leaves 
present bioactive coumpounds that have the 
therapeutic potential to treat several diseases 
related to hemostasis disorders. The present work 
highlights the high content of phenolic compounds 
and total flavonoids present in the extracts, which 
are probably related to the enzymes inhibition 
observed. The leaves of A. carambola 
significantly inhibit phospholipases A2 and 
proteases (mainly fibrinogenolytic and thrombin-
like). These classes of enzymes presented in the 
venoms have high structural and functional 
homology with human enzymes and are involved 
in processes such as blood coagulation cascade, 
platelet aggregation, tissue regeneration, and 
inflammatory and immune responses. Thus, the A. 
carambola leaves extract have a grea grerat 
potential for future use as therapeutic drugs. 
However, it is still needed further studies for the 
refinement of doses and the development of a 
suitable formulation for human consumption. 
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